Fri, 15 Jan 2021 15:03:21: Landos Biopharma guns for a $100M IPO to boost AI autoimmune R&D work

Fri, 15 Jan 2021 13:15:26: How a gene linked to the circadian clock could point to new prostate cancer treatments

Fri, 15 Jan 2021 12:51:41: NextCure nabs NexImmune, Celgene research vet as new CMO 6 months after former CMO quit

Fri, 15 Jan 2021 12:49:59: Sinopharm claims COVID-19 vaccine safe in kids aged 3 and up

Fri, 15 Jan 2021 10:49:34: Ex-Merck scientist accused of stealing trade secrets on Keytruda, raising threat of 10-year prison term

Fri, 15 Jan 2021 06:15:19: Chutes & LaddersóBristol Myers hematology chief Ahmed hits exit

Thu, 14 Jan 2021 14:27:57: Meet Binney Street Capital: Dana-Farber Cancer Institute's first venture fund

Thu, 14 Jan 2021 14:06:44: Knopp's oral asthma drug hits primary endpoint in phase 2

Thu, 14 Jan 2021 13:23:31: NewAmsterdam bags $196M to resurrect Amgen's discarded CETP drug

Thu, 14 Jan 2021 10:34:31: Eye stem cell transplant to treat blindness bolsters retinal function in monkeys

Thu, 14 Jan 2021 08:52:11: Secretive Sana, still a year away from the clinic, files for an IPO after a mammoth raise

Wed, 13 Jan 2021 14:40:01: JPM, Day 3: CureVac partner Bayer says not to discount its vaccine efforts, CROs better prepped for new wave and more

Wed, 13 Jan 2021 14:16:00: JPM: CureVac's new pharma partner Bayer says its COVID-19 vaccine not just an also-ran

Wed, 13 Jan 2021 13:25:54: Evoq pens $240M Amgen pact for next-gen autoimmune meds

Wed, 13 Jan 2021 12:10:34: A COVID-19 treatment candidate that fuses tiny antibodies from llamas and alpacas shows promise

Wed, 13 Jan 2021 11:25:03: Celltrion's COVID-19 antibody improves outcomes in phase 2

Wed, 13 Jan 2021 10:45:02: IO Biotech raises $155M to trial IDO and PD-L1 cancer vaccines

Wed, 13 Jan 2021 09:39:34: JPM: PPD C-suite says CROs 'better prepared' as COVID-19 surges, sees pandemic trials a long-term opportunity

Tue, 12 Jan 2021 18:20:30: Major hep B players Gilead and Vir join forces to find a cure

Tue, 12 Jan 2021 13:38:13: JPM, Day 2: Sanofi continues deal spree, Boehringer shines light on dark antigens and more

Tue, 12 Jan 2021 13:36:08: Pfizer invests $120M in 4 biotechs through new growth fund

Tue, 12 Jan 2021 09:51:03: JPM: Sanofi pays $125M to take lead in new checkpoint inhibitor space

Tue, 12 Jan 2021 09:43:33: JPM: Novartis CMO Tsai on how the pandemic is changing the face of biopharma R&D, how pharma works

Tue, 12 Jan 2021 09:03:46: JPM: Boehringer inks Enara deal to source 'dark antigens' for cancer immunotherapies

Tue, 12 Jan 2021 03:36:41: JPM: Verve Therapeutics unveils its lead programóa one-and-done treatment for genetic high cholesterol